These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

839 related articles for article (PubMed ID: 32524154)

  • 1. Drug-drug interactions with metronidazole and itraconazole in patients using acenocoumarol.
    Becker ML; van Uden RCAE; Giezen TJ; Meijer K; Houtenbos I; van den Bemt PMLA
    Eur J Clin Pharmacol; 2020 Oct; 76(10):1457-1464. PubMed ID: 32524154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugs.
    Penning-van Beest FJ; van Meegen E; Rosendaal FR; Stricker BH
    Clin Pharmacol Ther; 2001 Jun; 69(6):451-7. PubMed ID: 11406743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overanticoagulation associated with combined use of antibacterial drugs and acenocoumarol or phenprocoumon anticoagulants.
    Visser LE; Penning-van Bees FJ; Kasbergen AA; De Smet PA; Vulto AG; Hofman A; Stricker BH
    Thromb Haemost; 2002 Nov; 88(5):705-10. PubMed ID: 12428081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coumarin anticoagulants and co-trimoxazole: avoid the combination rather than manage the interaction.
    Schalekamp T; van Geest-Daalderop JH; Kramer MH; van Holten-Verzantvoort AT; de Boer A
    Eur J Clin Pharmacol; 2007 Apr; 63(4):335-43. PubMed ID: 17318526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants.
    Penning-van Beest FJ; Koerselman J; Herings RM
    J Thromb Haemost; 2008 Feb; 6(2):284-90. PubMed ID: 18031295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible drug-drug interaction between high-dose esomeprazole and phenprocoumon.
    Becker ML; Franken WP; Karapinar F; Verzijl-Zeegers R; Schalekamp T; van der Hoeven RT
    Eur J Clin Pharmacol; 2015 Dec; 71(12):1461-5. PubMed ID: 26400679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors and the risk of overanticoagulation during acenocoumarol maintenance treatment.
    Teichert M; van Noord C; Uitterlinden AG; Hofman A; Buhre PN; De Smet PA; Straus S; Stricker BH; Visser LE
    Br J Haematol; 2011 May; 153(3):379-85. PubMed ID: 21418179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overanticoagulation associated with combined use of antifungal agents and coumarin anticoagulants.
    Visser LE; Penning-van Beest FJ; Kasbergen AA; De Smet PA; Vulto AG; Hofman A; Stricker BH
    Clin Pharmacol Ther; 2002 Jun; 71(6):496-502. PubMed ID: 12087353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential interaction between acenocoumarol and diclofenac, naproxen and ibuprofen and role of CYP2C9 genotype.
    van Dijk KN; Plat AW; van Dijk AA; Piersma-Wichers M; de Vries-Bots AM; Slomp J; de Jong-van den Berg LT; Brouwers JR
    Thromb Haemost; 2004 Jan; 91(1):95-101. PubMed ID: 14691574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overanticoagulation associated with combined use of lactulose and acenocoumarol or phenprocoumon.
    Visser LE; Penning-van Beest FJ; Wilson JH; Vulto AG; Kasbergen AA; De Smet PA; Hofman A; Stricker BH
    Br J Clin Pharmacol; 2004 Apr; 57(4):522-4. PubMed ID: 15025752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic variants of cytochrome P450 2C9 modify the interaction between nonsteroidal anti-inflammatory drugs and coumarin anticoagulants.
    Visser LE; van Schaik RH; van Vliet M; Trienekens PH; De Smet PA; Vulto AG; Hofman A; van Duijn CM; Stricker BH
    Clin Pharmacol Ther; 2005 Jun; 77(6):479-85. PubMed ID: 15961979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin re-uptake inhibiting antidepressants and the risk of overanticoagulation during acenocoumarol maintenance treatment.
    Teichert M; Visser LE; Uitterlinden AG; Hofman A; Buhre PJ; Straus S; De Smet PA; Stricker BH
    Br J Clin Pharmacol; 2011 Nov; 72(5):798-805. PubMed ID: 21545482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acenocoumarol stabilization is delayed in CYP2C93 carriers.
    Schalekamp T; van Geest-Daalderop JH; de Vries-Goldschmeding H; Conemans J; Bernsen Mj Mj; de Boer A
    Clin Pharmacol Ther; 2004 May; 75(5):394-402. PubMed ID: 15116052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status: interaction between both genotypes affects overanticoagulation.
    Schalekamp T; Brassé BP; Roijers JF; Chahid Y; van Geest-Daalderop JH; de Vries-Goldschmeding H; van Wijk EM; Egberts AC; de Boer A
    Clin Pharmacol Ther; 2006 Jul; 80(1):13-22. PubMed ID: 16815313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of acenocoumarol and sitaxentan in pulmonary arterial hypertension.
    Pulido T; Sandoval J; Roquet I; Gutiérrez R; Rueda T; Peña H; Santos E; Miranda MT; Lupi E
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():14-8. PubMed ID: 19335742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of overanticoagulation in patients with heart failure on coumarin anticoagulants.
    Visser LE; Bleumink GS; Trienekens PH; Vulto AG; Hofman A; Stricker BH
    Br J Haematol; 2004 Oct; 127(1):85-9. PubMed ID: 15384981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased INR after gefitinib and acenocoumarol co-administration.
    Ribed A; Escudero-Vilaplana V; Gonzalez-Haba E; Sanjurjo M
    Eur Rev Med Pharmacol Sci; 2014; 18(12):1720-2. PubMed ID: 24992614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatment.
    Gschwind L; Rollason V; Boehlen F; Rebsamen M; Combescure C; Grünenwald M; Matthey A; Bonnabry P; Dayer P; Desmeules JA
    Pharmacogenomics; 2013 May; 14(7):745-53. PubMed ID: 23651023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of acenocoumarol and levofloxacin interaction in elderly institutionalized patients.
    Taberner-Bonastre P; Moreno-Miralles A; Quintana-Vargas I; Peris-Martí JF
    Farm Hosp; 2019 Mar; 43(2):53-55. PubMed ID: 30848177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Main comedications associated with major bleeding during anticoagulant therapy with coumarins.
    Penning-van Beest F; Erkens J; Petersen KU; Koelz HR; Herings R
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):439-44. PubMed ID: 15947920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.